Exchange: NASDAQ·Updated 08:10 AM EDT
News
all
press releases
Viatris Sharpens Focus with Divestiture, Hikes 2026 Outlook
Viatris sells Tyrvaya to Harrow for up to $100 million, raises 2026 guidance after second-quarter earnings and revenue beat estimates.read more...
Benzinga
More News
VTRS Q2 Earnings Beat, Revenues Rise 5% as Greater China Sales Jump
Viatris tops Q2 earnings and revenue estimates as Greater China sales surge 21%, helping lift results and prompting a higher 2026 financial outlook.
Zacks
Compared to Estimates, Viatris (VTRS) Q2 Earnings: A Look at Key Metrics
Although the revenue and EPS for Viatris (VTRS) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Zacks
Viatris (VTRS) Beats Q2 Earnings and Revenue Estimates
Viatris (VTRS) delivered earnings and revenue surprises of +11.29% and +2.19%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Viatris Posts Wider Loss In Q2; Raises 2026 Guidance
(RTTNews) - Viatris Inc. (VTRS) reported a second-quarter net loss of $118.8 million compared to a net loss of $4.6 million, a year ago. GAAP diluted loss per share was $0.10 compared to a loss of less than $0.01 per share. The loss in the second quarter was primarily driven by a...
Nasdaq News: Markets
Viatris Reports Second-Quarter 2026 Financial Results
Viatris Reports Second-Quarter 2026 Financial Results Viatris Reports Second-Quarter 2026 Financial Results PR Newswire PITTSBURGH, Aug. 6, 2026 Delivers Total Revenues of $3.8 Billion, Representing 5% Reported Growth Compared to Second Quarter 2025 and a U.S. GAAP Net Loss of $119 MillionTotal...
PR Newswire
Viatris (VTRS) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
Beyond analysts' top-and-bottom-line estimates for Viatris (VTRS), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2026.
Zacks
CVS Health (CVS) Q2 Earnings and Revenues Beat Estimates
CVS Health (CVS) delivered earnings and revenue surprises of +37.97% and +5.91%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Viatris Gears Up to Report Q2 Earnings: What's in the Cards?
VTRS readies Q2 results as growth in key markets and brands may offset manufacturing and pricing headwinds across parts of its portfolio.
Zacks
Viatris Announces Quarterly Dividend
Viatris Announces Quarterly Dividend Viatris Announces Quarterly Dividend PR Newswire PITTSBURGH, Aug. 4, 2026 PITTSBURGH, Aug. 4, 2026 /PRNewswire/ -- Viatris Inc.(Nasdaq: VTRS) today announced that on August 3, 2026, its Board of Directors declared a quarterly dividend of $0.12 per share for each...
PR Newswire

Advertisement|Remove ads.